Illumavista Biosciences, LLC

Madison, WI 53719

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.16MM
First Award Date 09/16/11
Most Recent Award Date 04/01/16

Key Personnel

Last Name Name Awards Contact
Ozers Mary Szatkowski Ozers 5
Warren Christopher L Warren 3

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-215
Budget: 04/01/16 - 03/31/17

DESCRIPTION (provided by applicant): Aptamer-Based Detection of Cardiac Biomarker Glycosylation States Using APT-SNAP Arrays PIs: Christopher L. Warren and Mary S. Ozers The presence of cardiac-related biomarkers in patient biospecimens can provide important insight into diagnosis of cardiovascular disease, its progression, and optimal therapies...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-215
Budget: 09/01/14 - 07/31/15

DESCRIPTION (provided by applicant): Aptamer-Based Detection of Cardiac Biomarker Glycosylation States Using APT-SNAP Arrays PIs: Christopher L. Warren and Mary S. Ozers The presence of cardiac-related biomarkers in patient biospecimens can provide important insight into diagnosis of cardiovascular disease, its progression, and optimal therapies...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-10-013
Budget: 09/01/12 - 08/31/13

Project Summary High Throughput Method to Assess SNP Functionality in Prostate Cancer PIs: Christopher L. Warren and Mary S. Ozers A critical unmet need in implementing personalized medicine is the ability to sort through the millions of single nucleotide polymorphisms (SNPs) present in the human genome and to pinpoint which of these DNA variat...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-10-013
Budget: 09/21/11 - 08/31/12

DESCRIPTION (provided by applicant): A critical unmet need in implementing personalized medicine is the ability to sort through the millions of single nucleotide polymorphisms (SNPs) present in the human genome and to pinpoint which of these DNA variations are causative in disease. A key under-studied function of SNPs is their ability to genera...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/16/11 - 08/31/13

DESCRIPTION (provided by applicant): Estrogen receptor a (ERa) is the major therapeutic target for breast cancer, and ERa binding at target genes in breast cancer cells is guided by DNA binding pioneer factor proteins such as FoxA1. Although tamoxifen is a successful therapeutic for suppressing ER-mediated gene regulation, resistance to tamoxife...